- Ongoing, recruitingTherapeutic exploratory (Phase II)
“Impact of CardiolRx on Myocardial Recovery in patients with Acute Myocarditis. A double-blind, placebo-controlled trial (ARCHER)”
This study, called ARCHER, is testing a new medicine called CardiolRx for people with a heart condition called acute myocarditis. We want to see if CardiolRx helps the heart heal better after 12 weeks compared to a dummy medicine. We'll use special heart scans to check.
For: Acute MyocarditisFrance - AuthorisedTherapeutic confirmatory (Phase III)
IMpAct of CardiolRxTM oVer 6 months following IL-1 Blocker cessation in pERICarditis patients – MAVERIC: A randomized, double-blind, placebo-controlled trial
This study is testing a new medicine, CardiolRx, for people who have recurring episodes of pericarditis, which is swelling around the heart. It wants to see if CardiolRx can help prevent these episodes after stopping another treatment called an IL-1 blocker.
For: Recurrent PericarditisGreece · Italy